• No results found

University of Groningen A quest to optimize the clinical pharmacology of tuberculosis and human immunodeficiency virus drug treatment Daskapan, Alper

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen A quest to optimize the clinical pharmacology of tuberculosis and human immunodeficiency virus drug treatment Daskapan, Alper"

Copied!
3
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

A quest to optimize the clinical pharmacology of tuberculosis and human immunodeficiency

virus drug treatment

Daskapan, Alper

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from

it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date:

2018

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Daskapan, A. (2018). A quest to optimize the clinical pharmacology of tuberculosis and human

immunodeficiency virus drug treatment. Rijksuniversiteit Groningen.

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

Samenvatting

Dankwoord

Curriculum Vitae

(3)

173

11

Curriculum Vitae

Alper Daskapan

Born on the 2nd of July 1990 in The Hague, The Netherlands

2018 – present

Hospital pharmacist in training

Tergooi, Hilversum/Blaricum, The Netherlands

2017 – 2018

Pharmacist

University Medical Center Groningen, Groningen, The Netherlands

2015 – 2017

Pharmacist/researcher

Amphia Ziekenhuis, Breda, The Netherlands

2013 – 2018

PhD student (part-time)

University Medical Center Groningen, Groningen, The Netherlands

2012 – 2015

Master of Science, Pharmacy

University of Groningen, Groningen, The Netherlands

2009 – 2012

Bachelor of Science, Pharmacy

University of Groningen, Groningen, The Netherlands

2002 – 2009

V.W.O.

Referenties

GERELATEERDE DOCUMENTEN

A quest to optimize the clinical pharmacology of tuberculosis and human immunodeficiency virus drug treatment..

A quest to optimize the clinical pharmacology of tuberculosis and human immunodeficiency virus drug treatment..

In this systematic review we chose to include all articles with data on the effect of HIV infection on the PK of the FLDs to prevent loss of information and therefore studies

Prolonged treatment is indicated, for example, for patients with drug-susceptible pulmonary TB who have cavitation on the initial chest X-ray and still have positive sputum

To further illustrate the inter-individual and intra-individual variability, the table shows the 10-h pharmacokinetics of raltegravir 800 mg twice daily in four patients

Development and Validation of a Bioanalytical Method for the Simul- taneous Determination of 14 Antiretroviral Drugs using Liquid Chro- matography-Tandem Mass Spectrometry..

The aim of this study was to investigate which kind of model best describes the data from our outpatient setting by using the two published models as priors to our own modelling

A controlled food effect study in patients is needed to optimize recommendations on the minimal amount of concomitant food intake to prevent unnecessary high caloric- and fat intake